Financials Boditech Med Inc.

Equities

A206640

KR7206640005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 23:00:00 23/06/2024 BST 5-day change 1st Jan Change
16,360 KRW +2.89% Intraday chart for Boditech Med Inc. -3.31% -20.20%

Valuation

Fiscal Period: December 2019 2020 2022 2023 2024 2025 2026
Capitalization 1 221,593 545,546 225,170 450,360 353,145 - -
Enterprise Value (EV) 2 221.6 545.5 225.2 383.3 254.8 225.4 198.2
P/E ratio 19 x 12 x 9.49 x 17.4 x 10.2 x 9.76 x 8.17 x
Yield - - - 0.98% 1.24% 1.09% 1.24%
Capitalization / Revenue - 3.79 x - 3.33 x 2.22 x 2.03 x 1.75 x
EV / Revenue - 3.79 x - 2.84 x 1.6 x 1.3 x 0.98 x
EV / EBITDA - - - 11.7 x 5.21 x 4.46 x 3.35 x
EV / FCF - - - 12.9 x 9.65 x 8.59 x 7.01 x
FCF Yield - - - 7.75% 10.4% 11.6% 14.3%
Price to Book - - - 2.42 x 1.64 x 1.46 x 1.22 x
Nbr of stocks (in thousands) 22,963 23,019 21,968 21,969 21,975 - -
Reference price 3 9,650 23,700 10,250 20,500 16,070 16,070 16,070
Announcement Date 30/03/20 17/02/21 20/03/23 19/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2022 2023 2024 2025 2026
Net sales 1 - 144.1 - 135.2 158.8 173.9 201.4
EBITDA 1 - - - 32.69 48.9 50.55 59.2
EBIT 1 - 65.51 - 28.64 39.2 42.95 50.6
Operating Margin - 45.45% - 21.19% 24.69% 24.7% 25.12%
Earnings before Tax (EBT) 1 - - - 31.89 43.7 48 54.9
Net income 1 11.65 47.7 24.15 27.41 37 38.85 46.2
Net margin - 33.1% - 20.27% 23.3% 22.34% 22.94%
EPS 2 507.0 1,976 1,080 1,181 1,573 1,646 1,967
Free Cash Flow 3 - - - 29,695 26,400 26,250 28,300
FCF margin - - - 21,966.26% 16,624.69% 15,094.88% 14,051.64%
FCF Conversion (EBITDA) - - - 90,836.71% 53,987.73% 51,928.78% 47,804.05%
FCF Conversion (Net income) - - - 108,347.61% 71,351.35% 67,567.57% 61,255.41%
Dividend per Share 2 - - - 200.0 200.0 175.0 200.0
Announcement Date 30/03/20 17/02/21 20/03/23 19/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 35.89 33.1 36.7 41.4 47.6
EBITDA - - - - - -
EBIT 1 - 6.903 5.9 8 10.5 14.8
Operating Margin - 19.23% 17.83% 21.8% 25.36% 31.09%
Earnings before Tax (EBT) - - - - - -
Net income 1 9.237 - - 7.8 8.8 9.5
Net margin - - - 21.25% 21.26% 19.96%
EPS 420.0 - - - - -
Dividend per Share - - - - - -
Announcement Date 14/11/23 19/02/24 07/05/24 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - - 67 98.3 128 155
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 2 - - - 29,695 26,400 26,250 28,300
ROE (net income / shareholders' equity) - 47.1% - 15% 18.3% 16.5% 16.7%
ROA (Net income/ Total Assets) - - - 12.3% 15.3% 14.1% 14.6%
Assets 1 - - - 223.7 241.8 276.5 316.4
Book Value Per Share 3 - - - 8,476 9,811 10,985 13,180
Cash Flow per Share - - - 1,561 - - -
Capex 1 - - - 4.6 9 9.35 15.7
Capex / Sales - - - 3.41% 5.67% 5.38% 7.8%
Announcement Date 30/03/20 17/02/21 20/03/23 19/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16,070 KRW
Average target price
24,500 KRW
Spread / Average Target
+52.46%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A206640 Stock
  4. Financials Boditech Med Inc.